Could cold plasma be the next acne breakthrough?
NCT ID NCT07056673
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether cold atmospheric plasma (CAP) can safely and effectively treat moderate-to-severe acne. 220 adults aged 18-40 will receive either CAP or a placebo treatment once a week for six weeks. The goal is to see if CAP reduces acne lesions better than placebo, offering a potential new option without the side effects of standard medications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- cold atmospheric plasma (CAP) delivered via patch or jet device
- What this could lead to
- If it works, this could offer a new, non-drug option for stubborn acne with fewer side effects than current treatments.
- What could go wrong
- This is an early-phase trial with no prior large-scale evidence. The effect may be small or no better than placebo, and results may not apply to all skin types.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACNE VULGARIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
the 989th Hospital of Chinese People's Liberation Army Joint Logistic Support Force
RECRUITINGLuoyang, Henan, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a gentle cream outperform harsh acne drugs?
- Can acne drug harm the eyes? new study investigates
- A new serum aims to clear acne and boost skin confidence
- Head-to-Head: which acne cream works better for clear skin?
- Acne Treatment's Oil-Reducing power put to the test
- AI writes acne guide, students score same as human version